Hing C Wong

Weston, FL, United States of America

Hing C Wong

This inventor holds 112 USPTO granted patents and 41 published patent applications, plus 6 CIPO patents and 27 EPO patents, primarily in Chimeric Polypeptides (CPC class C07K14-5443). Top assignees: Altor Bioscience Corporation, Hcw Biologics, Inc., Immunitybio, Inc.. Active years: 1987-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hing C Wong. Retrieved from https://idiyas.com/inventor/hing-c-wong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 112 

% Patents Active = 87.5

 

 

Average Co-Inventor Count = 2.7

ph-index = 24

Forward Citations = 1,777(Granted Patents)

Forward Citations (Not Self Cited) = 1,073(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • San Ramon, CA (US) (1987 - 1998)
  • Ft. Lauderdale, FL (US) (1996 - 1999)
  • Fort Lauderdale, FL (US) (1999 - 2011)
  • Weston, FL (US) (2003 - 2024)
  • Miramar, FL (US) (2022 - 2024)
  • Culver City, CA (US) (2023 - 2024)

Company Filing History:


Years Active: 1987-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Chimeric Polypeptides
IL-15 Variants
Neuroinflammation
T-cell Memory
Anti-CD26 Proteins
Cancer Treatment
Immune Checkpoint Inhibition
Regulatory T Cells
Fusion Molecules
Aging Disorders
Neoplasia
Chromatography Resin
112 patents (USPTO):Explore Patents

Title: The Innovative Mind of Hing C Wong

Introduction

Hing C Wong is a renowned inventor based in Weston, FL, who has made significant contributions to the field of biotechnology. With an impressive portfolio of 100 patents, his work primarily focuses on enhancing immune responses and developing effective therapies for cancer and infectious diseases. His inventions are at the forefront of medical innovation, bridging the gap between research and clinical application.

Latest Patents

Among Hing C Wong's most notable patents are the following:

1. **Multimeric IL-15 soluble fusion molecules and methods of making and using same** - This invention features compositions and methodologies involving ALT-803, which includes a complex of an interleukin-15 (IL-15) superagonist mutant combined with a dimeric IL-15 receptor α/Fc fusion protein. This innovative solution is designed to enhance immune responses against various neoplasms, including multiple myeloma, melanoma, and lymphoma, as well as viral infections such as human immunodeficiency virus.

2. **BCG and IL-15 based molecules** - This patent outlines combination therapies utilizing an IL-15-based superagonist complex in conjunction with an antibody. Such innovations aim to effectively treat subjects suffering from cancer and infectious diseases, leveraging the synergistic potential of these compounds.

Career Highlights

Hing C Wong has had a successful career with significant contributions to key biotechnology companies. He has worked with Altor Bioscience Corporation, where he was involved in groundbreaking projects focused on immune enhancement. Additionally, his tenure at Sunol Molecular Corporation allowed him to push the boundaries of molecular diagnostics and therapeutics.

Collaborations

Throughout his career, Wong has collaborated with several talented individuals, enhancing the innovative potential of his work. Notable collaborations include working alongside Peter Rhode and Bai Liu, both of whom have contributed to advancing his research efforts and expanding the implications of his inventions.

Conclusion

Hing C Wong stands out as a prominent inventor in the field of biotechnology, with a remarkable portfolio of patents that are shaping the future of medical treatment. His dedication to improving immune responses and treatment strategies for cancer and infectious diseases demonstrates his commitment to innovation. With each new patent, Wong is paving the way for significant advancements that can benefit countless patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…